Jeff Lee, CEO, mProve Health, was recently featured in the May issue of Prostatepedia, a monthly periodical featuring conversations with leading medical experts in the prostate cancer world. He discusses how mobile technology affects oncology clinical trials and explains what mHealth applications can do for cancer patients in research studies.
Check out this feature in BioPharma Dive on how mProve Health’s mobile technology is helping patients who participate in clinical trials. CSO Denis Curtin weighs in on the mobile evolution in pharma and how mCast SMS recruiting helped us become industry leaders. To read the full article, click here.
BYOD has been a buzzword in the clinical trial space since mProve Health got started in 2010. We have seen the movement go from risky and heavily-hyped to a conservatively accepted. From our start in ePRO, we’ve been driving the BYOD bandwagon. Now, though, we want to pull over and ask for directions. That stopover is CYOD.
On October 21st, I was honored to present at the 2016 Bioinformatics & Computational Biosciences Festival, Virtual Clinical Trials: Modernizing Comparative Studies, hosted by the National Institute of Allergy and Infectious Diseases. The event focused on the emerging model of less site-centric studies, and how tech is helping enable this new model. (more…)